The research team led by Professor Lee Minho from the Department of Microbiology at Hallym University College of Medicine recently received both the ...
The mandatory Phase 1 clinical trial in healthy volunteers in China precedes the inclusion of Chinese clinical sites by late 2026 into the single Global Phase 3 registration trial of BV100 in ...
It’s hard to believe that infectious diseases have become a political litmus test, but they are now very much part of the ...
Shanghai Zhimeng Biopharma Inc. ( "Zhimeng") announced that its self-developed new-generation potassium channel opener CB03-154 for the treatment of amyotrophic lateral sclerosis (ALS) has officially ...
One of the most common genetic diseases, AATD, involves the retention of misfolded alpha 1 antitrypsin (AAT) in hepatocytes, ...
ID, A NATIONAL UNIVERSITY OF SINGAPORE LED TRIAL NETWORK, IN PARTNERSHIP WITH BIOVERSYS Ad hoc announcement pursuant to Art. 53 LR BASEL, Switzerland, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Panel of ...
New data from Eli Lilly and Company showed Omvoh-treated patients with moderately to severely active ulcerative colitis (UC) and bowel urgency experienced early improvements in bowel urgency severity, ...
UCB, a global biopharmaceutical company, today announced new three-year data from Phase 3 trials, and their open-label extensions, investigating BIMZELX (R) (bimekizumab-bkzx) in adults with active ...
The number of people diagnosed with tuberculosis worldwide rose again last year, eclipsing 2023's record total.
1hon MSN
New tuberculosis cases and deaths fell in 2024, but health experts are still worried. Here’s why
While rates of new TB cases and deaths fell in 2024, global health officials say global health funding cuts could endanger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback